JP2004513369A5 - - Google Patents

Download PDF

Info

Publication number
JP2004513369A5
JP2004513369A5 JP2002541398A JP2002541398A JP2004513369A5 JP 2004513369 A5 JP2004513369 A5 JP 2004513369A5 JP 2002541398 A JP2002541398 A JP 2002541398A JP 2002541398 A JP2002541398 A JP 2002541398A JP 2004513369 A5 JP2004513369 A5 JP 2004513369A5
Authority
JP
Japan
Prior art keywords
platelet
blood
edta
ctad
platelets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002541398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513369A (ja
Filing date
Publication date
Priority claimed from GBGB0027309.4A external-priority patent/GB0027309D0/en
Application filed filed Critical
Publication of JP2004513369A publication Critical patent/JP2004513369A/ja
Publication of JP2004513369A5 publication Critical patent/JP2004513369A5/ja
Pending legal-status Critical Current

Links

JP2002541398A 2000-11-08 2001-11-08 血小板活性の測定方法 Pending JP2004513369A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation
PCT/GB2001/004946 WO2002039124A1 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation

Publications (2)

Publication Number Publication Date
JP2004513369A JP2004513369A (ja) 2004-04-30
JP2004513369A5 true JP2004513369A5 (cg-RX-API-DMAC10.html) 2005-04-28

Family

ID=9902807

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002541398A Pending JP2004513369A (ja) 2000-11-08 2001-11-08 血小板活性の測定方法

Country Status (9)

Country Link
US (1) US7011938B2 (cg-RX-API-DMAC10.html)
EP (1) EP1332373B1 (cg-RX-API-DMAC10.html)
JP (1) JP2004513369A (cg-RX-API-DMAC10.html)
AT (1) ATE522808T1 (cg-RX-API-DMAC10.html)
AU (2) AU1252902A (cg-RX-API-DMAC10.html)
CA (1) CA2428224C (cg-RX-API-DMAC10.html)
ES (1) ES2372810T3 (cg-RX-API-DMAC10.html)
GB (1) GB0027309D0 (cg-RX-API-DMAC10.html)
WO (1) WO2002039124A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392724A (en) * 2002-09-06 2004-03-10 Ian Stoakes Methods of and apparatus for blood analysis
EP1814563A4 (en) * 2004-07-26 2008-04-16 Bayer Healthcare Llc PLATTOCK ACTIVATING MARKERS AS PREDICATORS OF ILLNESSES AND THE RESPONSE TO TREATMENTS AND MONITORING THERAPEUTIC PROGRESS
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US20090185973A1 (en) * 2008-01-22 2009-07-23 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US10575515B2 (en) 2010-05-04 2020-03-03 The General Hospital Corporation Methods and compositions for preserving tissues and organs
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
ES2968371T3 (es) 2013-10-10 2024-05-09 Eastern Virginia Medical School Derivados de 4-((2-hidroxi-3-metoxibencil)amino) bencenosulfonamida como inhibidores de la 12-lipoxigenasa
JP6687601B2 (ja) * 2014-08-07 2020-04-22 ザ ジェネラル ホスピタル コーポレイション 全血サンプルの安定化
US10908171B2 (en) 2016-07-12 2021-02-02 EMULATE, Inc. Additive channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220094A (ja) * 1995-02-08 1996-08-30 Dai Ichi Pure Chem Co Ltd 血漿中gmp−140の測定法
FR2731277A1 (fr) * 1995-03-02 1996-09-06 Benveniste Jacques Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins
US5817519A (en) * 1995-12-28 1998-10-06 Bayer Corporation Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease

Similar Documents

Publication Publication Date Title
Macey et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system
US6664110B1 (en) Erythroblast diagnostic flow-cytometry method and reagents
Lyberg Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies
Buttarello et al. Automated blood cell counts: state of the art
US5858790A (en) Hematology reference control and method of preparation
AU669692B2 (en) Suspension media for hematological composition and method for its use
JP2557837B2 (ja) 白血球の3つの母集団についての血液学規準コントロール流体懸濁物およびその製造方法
US6524858B1 (en) Single channel, single dilution detection method for the identification and quantification of blood cells and platelets in a whole blood sample using an automated hematology analyzer
JP3704654B2 (ja) 全血サンプルを使用して血小板を同定および定量し、血小板の活性化状態を測定する高感度で正確かつ精密な自動化方法
US5786224A (en) Reagent and method for differential determination of leukocytes in blood
Ahnadi et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy
EP0846264B1 (en) Reagent and method for differential determination of leukocytes in blood
Zelmanovic et al. Automated analysis of feline platelets in whole blood, including platelet count, mean platelet volume, and activation state
EP1766045B1 (en) Hematology reference control containing an immature granulocyte component
Riley et al. Reticulocyte analysis by flow cytometry and other techniques
Chapman et al. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination
US7449337B2 (en) Lytic reagent and method for leukocytes differential in whole blood
EP1332373B1 (en) Method of measuring leucocyte activation
EP2291652B1 (en) Stabilisation of blood cell conjugates
AU2002212529A1 (en) Method of measuring platelet activation
Lee et al. Changes of hematological references depends on storage period and temperature conditions in rats and dogs
US6852534B2 (en) Method to determine an engrafting cell dose of hematopoietic stem cell transplant units
Nemec et al. The effect of high anticoagulant k3-edta concentration on complete blood count and white blood cell differential counts in healthy beagle dogs
Fiore et al. Procoagulant platelet characterization by measuring phosphatidylserine exposure and microvesicle release from human purified platelets
Solanki et al. Spurious red blood cell parameters due to serum cold agglutinins: Observations on Ortho ELT-8® Cell Counter